アメリカの心臓用医療機器市場:心調律管理デバイス、心臓補助デバイス、心臓弁

◆英語タイトル:Cardiac Medical Devices Market in the US 2016-2020
◆商品コード:IRTNTR8830
◆発行会社(調査会社):Technavio
◆発行日:2016年2月24日
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:米国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥252,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥303,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥404,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、アメリカの心臓用医療機器市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、アメリカの心臓用医療機器市場規模及び予測、製品別分析、市場シェア、市場の成長要因、市場の課題、医療費償還シナリオ、市場動向、競争状況などの情報をお届けいたします。
【レポートの概要】

About Cardiac Medical Devices Market in the US

Atrial fibrillation (AF), a common type of heart arrhythmia, is a heart condition when the heart beats too fast or too slow or in an irregular way. An estimation done by the Centers for Disease Control and Prevention (CDC) in 2015 shows that in the US 2.7-6.1 million people were diagnosed with AF. It is most common in the older population, among people aged 60 years or above. This condition occurs when the heart’s ability to function reduces and there is a malfunction in the electrical impulses in the heart, which leads to sudden cardiac arrest or heart failure.
Cardiac output such as an irregularity in the ventricular rate can lead to diastolic dysfunction. Hence, to reduce the risk of irregular heartbeat, especially for people that are at a higher risk of arrhythmia or have recurrent arrhythmia, cardiac medical devices such as pacemaker or implantable cardioverter defibrillators (ICD) are used to help the heart’s electrical activity and heart rhythm function. These devices are small and are placed below the collar bone. Heart attacks can also cause defects in the heart valves, which can be replaced by mechanical or tissue heart valves.

Technavio’s analysts forecast the cardiac medical devices market in the US to grow at a CAGR of 1.82% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the cardiac medical devices market in the US for 2016-2020. Cardiac medical devices that are included in this report are implanted in the heart through minimally invasive surgeries. To calculate the market size, the report considers the revenue generated from the sales of the products.

The market is divided into the following segments based on product type:
• Cardiac rhythm management (CRM) devices
• Cardiac assist devices
• Heart valve

Technavio’s report, Cardiac Medical Devices Market in the US 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Boston Scientific
• LivaNova
• Medtronic
• St. Jude Medical

[Other prominent vendors]
• Abiomed
• Adam, Rouilly
• Advanced Instrumentations
• A.M.I. ITALIA
• Biotronik
• Cardioline
• Cardia International
• Cardiac Science (subsidiary of Opto Circuits)
• Colibri Heart Valve
• Corpuls
• Edwards Lifesciences
• EMTEL
• Fukuda Denshi
• HeartWare
• Innomed
• INSTRAMED
• MEDIANA
• M&B Electronic Instruments
• Medical ECONET
• Mindray Medical
• Physio Control
• PRIMEDIC
• Prestan
• Schiller
• Spectranetics
• SynCardia
• Symetis
• TTK Healthcare
• WNL Products

[Market driver]
• Prevalence of cardiac disorders
• For a full, detailed list, view our report

[Market challenge]
• High cost of cardiac devices
• For a full, detailed list, view our report

[Market trend]
• Increase in M&A
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Product offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Regulation and reimbursement scenario in US
• Average price provided by Medicare for cardiac medical device implantation

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Market segmentation by product type
• CRM devices
• CRM devices market in US
• Cardiac assist devices
• Cardiac assist devices market in US
• Heart valves
• Heart valves market in US

PART 08: Market drivers
• Prevalence of cardiac disorders
• Shortage of heart donors
• Increase in public awareness

PART 09: Impact of drivers

PART 10: Market challenges
• Product recalls
• High cost of cardiac devices
• Regulatory complications
• Intense competition
• Complications of CRM devices

PART 11: Impact of drivers and challenges

PART 12: Market trends
• Use of MRI in clinical applications
• Popularity of robot-assisted surgery
• Increase in M&A

PART 13: Vendor landscape
• Competitive scenario
• Market share analysis
• Boston Scientific
• Medtronic
• LivaNova
• St. Jude Medical
• Other prominent vendors

PART 14: Appendix
• List of abbreviations

PART 15: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Progression of heart failure due to AF
Exhibit 03: Types of cardiac medical devices
Exhibit 04: Snapshot of regulatory pathway for medical devices in US
Exhibit 05: Reimbursement scenario of cardiac medical devices in US
Exhibit 06: Cardiac medical devices market in US
Exhibit 07: Cardiac medical devices market in US 2015-2020 ($ billions)
Exhibit 08: Five forces analysis
Exhibit 09: Segmentation of cardiac medical devices based on products
Exhibit 10: Cardiac medical devices market segmentation by product type 2015
Exhibit 11: Segmentation of CRM devices market by product type 2015
Exhibit 12: Segmentation of cardiac assist devices market by product type 2015
Exhibit 13: Segmentation of heart valves market by product type 2015
Exhibit 14: CRM devices market in US 2015-2020 ($ billions)
Exhibit 15: Cardiac assist devices market in US 2015-2020 ($ millions)
Exhibit 16: Heart valves market in US 2015-2020 ($ billions)
Exhibit 17: Impact of drivers
Exhibit 18: US FDA-initiated product recalls in 2013 and 2014
Exhibit 19: Impact of drivers and challenges
Exhibit 20: Ranking of CRM vendors 2015
Exhibit 21: Ranking of cardiac assist devices vendors 2015
Exhibit 22: Ranking of heart valves vendors 2015
Exhibit 23: Boston Scientific: Business segmentation by revenue 2014
Exhibit 24: Boston Scientific: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 25: Boston Scientific: Geographical segmentation by revenue 2014
Exhibit 26: Boston Scientific: Key takeaways
Exhibit 27: Medtronic: Business segmentation by revenue 2015
Exhibit 28: Medtronic: Business segmentation by revenue 2014 and 2015 ($ billions)
Exhibit 29: Medtronic: Geographical segmentation by revenue 2015
Exhibit 30: Medtronic: Key takeaways
Exhibit 31: LivaNova: Business segmentation by revenue 2014
Exhibit 32: LivaNova: Business segmentation by revenue 2013 and 2014 ($ millions)
Exhibit 33: LivaNova: Key takeaways
Exhibit 34: St. Jude Medical: Business segmentation by revenue 2014
Exhibit 35: St. Jude Medical: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 36: St. Jude Medical: Key takeaways



【掲載企業】

Boston Scientific, LivaNova, Medtronic, St. Jude Medical, Abiomed, Adam, Rouilly, Advanced Instrumentations, A.M.I. ITALIA, Biotronik, Cardioline, Cardia International, Cardiac Science (subsidiary of Opto Circuits), Colibri Heart Valve, Corpuls, Edwards Lifesciences, EMTEL, Fukuda Denshi, HeartWare, Innomed, INSTRAMED, MEDIANA, M&B Electronic Instruments, Medical ECONET, Mindray Medical, Physio Control, PRIMEDIC, Prestan, Schiller, Spectranetics, SynCardia, Symetis, TTK Healthcare, WNL Products.

【レポートのキーワード】

心調律管理デバイス、心臓補助デバイス、心臓弁、心臓、医療機器、アメリカ

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[アメリカの心臓用医療機器市場:心調律管理デバイス、心臓補助デバイス、心臓弁]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年09月25日現在 206,469 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆